126 related articles for article (PubMed ID: 37673586)
1. Malignant Mesothelioma subtyping via sampling driven multiple instance prediction on tissue image and cell morphology data.
Eastwood M; Marc ST; Gao X; Sailem H; Offman J; Karteris E; Fernandez AM; Jonigk D; Cookson W; Moffatt M; Popat S; Minhas F; Robertus JL
Artif Intell Med; 2023 Sep; 143():102628. PubMed ID: 37673586
[TBL] [Abstract][Full Text] [Related]
2. MesoGraph: Automatic profiling of mesothelioma subtypes from histological images.
Eastwood M; Sailem H; Marc ST; Gao X; Offman J; Karteris E; Fernandez AM; Jonigk D; Cookson W; Moffatt M; Popat S; Minhas F; Robertus JL
Cell Rep Med; 2023 Oct; 4(10):101226. PubMed ID: 37816348
[TBL] [Abstract][Full Text] [Related]
3. New Insights on Diagnostic Reproducibility of Biphasic Mesotheliomas: A Multi-Institutional Evaluation by the International Mesothelioma Panel From the MESOPATH Reference Center.
Galateau Salle F; Le Stang N; Nicholson AG; Pissaloux D; Churg A; Klebe S; Roggli VL; Tazelaar HD; Vignaud JM; Attanoos R; Beasley MB; Begueret H; Capron F; Chirieac L; Copin MC; Dacic S; Danel C; Foulet-Roge A; Gibbs A; Giusiano-Courcambeck S; Hiroshima K; Hofman V; Husain AN; Kerr K; Marchevsky A; Nabeshima K; Picquenot JM; Rouquette I; Sagan C; Sauter JL; Thivolet F; Travis WD; Tsao MS; Weynand B; Damiola F; Scherpereel A; Pairon JC; Lantuejoul S; Rusch V; Girard N
J Thorac Oncol; 2018 Aug; 13(8):1189-1203. PubMed ID: 29723687
[TBL] [Abstract][Full Text] [Related]
4. Benchmarking weakly-supervised deep learning pipelines for whole slide classification in computational pathology.
Ghaffari Laleh N; Muti HS; Loeffler CML; Echle A; Saldanha OL; Mahmood F; Lu MY; Trautwein C; Langer R; Dislich B; Buelow RD; Grabsch HI; Brenner H; Chang-Claude J; Alwers E; Brinker TJ; Khader F; Truhn D; Gaisa NT; Boor P; Hoffmeister M; Schulz V; Kather JN
Med Image Anal; 2022 Jul; 79():102474. PubMed ID: 35588568
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of biopsy sampling in predicting histology in patients with diffuse malignant pleural mesothelioma.
Chirieac LR; Hung YP; Foo WC; Hofer MD; VanderLaan PA; Richards WG; Sugarbaker DJ; Bueno R
Cancer; 2019 Dec; 125(23):4164-4171. PubMed ID: 31390057
[TBL] [Abstract][Full Text] [Related]
6. Highlighting the immunohistochemical differences of malignant mesothelioma subtypes via case presentations.
Sejben A; Pancsa T; Tiszlavicz L; Furák J; Paróczai D; Zombori T
Thorac Cancer; 2023 Apr; 14(10):857-863. PubMed ID: 36808895
[TBL] [Abstract][Full Text] [Related]
7. Deep learning-based classification of mesothelioma improves prediction of patient outcome.
Courtiol P; Maussion C; Moarii M; Pronier E; Pilcer S; Sefta M; Manceron P; Toldo S; Zaslavskiy M; Le Stang N; Girard N; Elemento O; Nicholson AG; Blay JY; Galateau-Sallé F; Wainrib G; Clozel T
Nat Med; 2019 Oct; 25(10):1519-1525. PubMed ID: 31591589
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of histologic subtyping of malignant pleural mesothelioma.
Brcic L; Kern I
Transl Lung Cancer Res; 2020 Jun; 9(3):924-933. PubMed ID: 32676358
[TBL] [Abstract][Full Text] [Related]
9. Reproducibility of histological subtyping of malignant pleural mesothelioma.
Brčić L; Jakopović M; Brčić I; Klarić V; Milošević M; Sepac A; Samaržija M; Seiwerth S
Virchows Arch; 2014 Dec; 465(6):679-85. PubMed ID: 25300229
[TBL] [Abstract][Full Text] [Related]
10. Interobserver variation in the assessment of the sarcomatoid and transitional components in biphasic mesotheliomas.
Dacic S; Le Stang N; Husain A; Weynand B; Beasley MB; Butnor K; Chapel D; Gibbs A; Klebe S; Lantuejoul S; Roden AC; Roggli V; Tazelaar H; Vignaud JM; Galateau-Sallé F
Mod Pathol; 2020 Feb; 33(2):255-262. PubMed ID: 31273316
[TBL] [Abstract][Full Text] [Related]
11. Three newly established immortalized mesothelial cell lines exhibit morphological phenotypes corresponding to malignant mesothelioma epithelioid, intermediate, and sarcomatoid types, respectively.
Sato T; Nakanishi H; Akao K; Okuda M; Mukai S; Kiyono T; Sekido Y
Cancer Cell Int; 2021 Oct; 21(1):546. PubMed ID: 34663305
[TBL] [Abstract][Full Text] [Related]
12. Pleomorphic epithelioid diffuse malignant pleural mesothelioma: a clinicopathological review and conceptual proposal to reclassify as biphasic or sarcomatoid mesothelioma.
Kadota K; Suzuki K; Sima CS; Rusch VW; Adusumilli PS; Travis WD
J Thorac Oncol; 2011 May; 6(5):896-904. PubMed ID: 21358344
[TBL] [Abstract][Full Text] [Related]
13. Authors' response: Mezei et al's "Comments on a recent case-control study of malignant mesothelioma of the pericardium and the tunica vaginalis testis".
Marinaccio A; Consonni D; Mensi C; Mirabelli D; Migliore E; Magnani C; Di Marzio D; Gennaro V; Mazzoleni G; Girardi P; Negro C; Romanelli A; Chellini E; Grappasonni I; Madeo G; Romeo E; Ascoli V; Carrozza F; Angelillo IF; Cavone D; Tumino R; Melis M; Curti S; Brandi G; Mattioli S; Iavicoli S;
Scand J Work Environ Health; 2021 Jan; 47(1):87-89. PubMed ID: 33388783
[TBL] [Abstract][Full Text] [Related]
14. IDA-MIL: Classification of Glomerular with Spike-like Projections via Multiple Instance Learning with Instance-level Data Augmentation.
Wu X; Chen Y; Li X; Liu X; Liu Y; Wu Y; Li M; Zhou X; Wang C
Comput Methods Programs Biomed; 2022 Oct; 225():107106. PubMed ID: 36088891
[TBL] [Abstract][Full Text] [Related]
15. Systematic review of response rates of sarcomatoid malignant pleural mesotheliomas in clinical trials.
Mansfield AS; Symanowski JT; Peikert T
Lung Cancer; 2014 Nov; 86(2):133-6. PubMed ID: 25217189
[TBL] [Abstract][Full Text] [Related]
16. Survival by Histologic Subtype of Malignant Pleural Mesothelioma and the Impact of Surgical Resection on Overall Survival.
Verma V; Ahern CA; Berlind CG; Lindsay WD; Shabason J; Sharma S; Culligan MJ; Grover S; Friedberg JS; Simone CB
Clin Lung Cancer; 2018 Nov; 19(6):e901-e912. PubMed ID: 30224273
[TBL] [Abstract][Full Text] [Related]
17. Deep-learning based classification distinguishes sarcomatoid malignant mesotheliomas from benign spindle cell mesothelial proliferations.
Naso JR; Levine AB; Farahani H; Chirieac LR; Dacic S; Wright JL; Lai C; Yang HM; Jones SJM; Bashashati A; Yip S; Churg A
Mod Pathol; 2021 Nov; 34(11):2028-2035. PubMed ID: 34112957
[TBL] [Abstract][Full Text] [Related]
18. The potential utility of GATA binding protein 3 for diagnosis of malignant pleural mesotheliomas.
Prabhakaran S; Hocking A; Kim C; Hussey M; Klebe S
Hum Pathol; 2020 Nov; 105():1-8. PubMed ID: 32888937
[TBL] [Abstract][Full Text] [Related]
19. Pathohistological diagnosis and differential diagnosis.
Tischoff I; Neid M; Neumann V; Tannapfel A
Recent Results Cancer Res; 2011; 189():57-78. PubMed ID: 21479896
[TBL] [Abstract][Full Text] [Related]
20. E2EFP-MIL: End-to-end and high-generalizability weakly supervised deep convolutional network for lung cancer classification from whole slide image.
Cao L; Wang J; Zhang Y; Rong Z; Wang M; Wang L; Ji J; Qian Y; Zhang L; Wu H; Song J; Liu Z; Wang W; Li S; Wang P; Xu Z; Zhang J; Zhao L; Wang H; Sun M; Huang X; Yin R; Lu Y; Liu Z; Deng K; Wang G; Qiu M; Li K; Wang J; Hou Y
Med Image Anal; 2023 Aug; 88():102837. PubMed ID: 37216736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
